Early Expansion of CD19.CAR-T Cells in vivo identify the Patients at Risk for the Treatment Failure in diffuse large B-Cell Lymphoma

Blumenberg V, Busch G, Baumann S, Jitschin R, Winkelmann M, Hellwig K, Schmidt C, Froehlich L, Tast B, Hildebrand F, Rejeski K, Dekorsy F, Schmidkonz C, Bäuerle T, Kunz WG, Müller F, Mougiakakos D, Bergwelt M, Buecklein V, Mackensen A, Völkl S, Subklewe M (2022)

Publication Type: Conference contribution

Publication year: 2022

Journal

Oncology Research and Treatment Karger Publishers

Publisher: KARGER

City/Town: BASEL

Pages Range: 253-253

Conference Proceedings Title: ONCOLOGY RESEARCH AND TREATMENT

Authors with CRIS profile

Konstantin Hellwig Institute of Radiology Christian Schmidkonz Lehrstuhl für Klinische Nuklearmedizin Tobias Bäuerle Professur für Multimodale Bildgebung in der präklinischen Forschung Fabian Müller Department of Medicine 5 – Haematology and Oncology Dimitrios Mougiakakos Medizinische Fakultät Andreas Mackensen Lehrstuhl für Innere Medizin V Simon Völkl Department of Medicine 5 – Haematology and Oncology

Involved external institutions

LMU Klinikum DE Germany (DE) Universitätsklinikum der Ludwig-Maximilians-Universität München DE Germany (DE)

How to cite

APA:

Blumenberg, V., Busch, G., Baumann, S., Jitschin, R., Winkelmann, M., Hellwig, K.,... Subklewe, M. (2022). Early Expansion of CD19.CAR-T Cells in vivo identify the Patients at Risk for the Treatment Failure in diffuse large B-Cell Lymphoma. In ONCOLOGY RESEARCH AND TREATMENT (pp. 253-253). BASEL: KARGER.

MLA:

Blumenberg, V., et al. "Early Expansion of CD19.CAR-T Cells in vivo identify the Patients at Risk for the Treatment Failure in diffuse large B-Cell Lymphoma." Proceedings of the ONCOLOGY RESEARCH AND TREATMENT BASEL: KARGER, 2022. 253-253.

BibTeX: Download